| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.09 | 0.1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |